Development of the world's first digital model of a cancer cell
(Graz University of Technology) The computer model, developed under the lead management of researchers at TU Graz, simulates the cyclical changes in the membrane potential of a cancer cell using the example of human lung adenocarcinoma and opens up completely new avenues in cancer research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news
Scientists reveal a new therapeutic vulnerability in pancreatic cancer
(Columbia University Irving Medical Center) Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news
Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene
(Mayo Clinic) Research by investigators at Mayo Clinic Cancer Center suggests that physicians should screen patients with lung cancer for MET amplification/overexpression before determining a treatment strategy. Their findings are published Cancer Discovery, a journal of the American Association for Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news
94% of patients with cancer respond well to COVID-19 vaccines
(University of Texas Health Science Center at San Antonio) More than 9 of 10 patients with cancer showed good immune response to the COVID-19 mRNA vaccines after receiving both doses, but subsets of high-risk patients did not, according to a study conducted by researchers at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, and Swiss collaborators. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news
NIST-led study finds variations in quantitative MRI scanners' measurements
(National Institute of Standards and Technology (NIST)) Magnetic resonance imaging (MRI) is widely used in medicine to detect, diagnose and treat diseases such as cancer, while relying on experts' interpretation of images. Quantitative MRI, which obtains numerical measurements during the scans, can now potentially offer greater accuracy, repeatability and speed -- but rigorous quality control is needed for it to reach its full potential, according to a new study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news
World-first artificial intelligence study to map risks of ovarian cancer in women
(University of South Australia) The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most fatal reproductive cancer in women worldwide so it can be detected and treated earlier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news
Reactive oxygen species (ROS): Key components in cancer therapies
(Bentham Science Publishers) This review highlights the genesis of ROS within cells by various routes and their role in cancer therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news
RESILIENCE, a project to reduce the prevalence of heart failure in cancer survivors
(Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)) RESILIENCE is a multinational project funded by the European Commission through the H2020 " Health, Demographic Change and Wellbeing " programme. Eleven partners from six EU countries (Spain, France, The Netherlands, Portugal, Germany, Denmark) will work together under the coordination of the Spanish National Centre for Cardiovascular Research (CNIC). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news
MD Anderson research highlights for June 30, 2021
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include expanded use of a targeted therapy for a new group of patients with leukemia, molecular studies yielding novel cancer therapeutic targets, insights into radiation therapy resistance and a community intervention to reduce cervical cancer rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2021 Category: Cancer & Oncology Source Type: news
EORTC and Pierre Fabre partner to address treatment gap for stage 2 melanoma patients
(European Organisation for Research and Treatment of Cancer) European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma. The partnership includes the planning, design and execution of a large Phase 3 study investigating the use of BRAF and MEK targeted therapies to reduce the risk of relapse in this patient population, currently under approval with authorities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
BU receives $2.7M from the AHA to address disparities that intersect heart disease
(Boston University School of Medicine) With a growing need to better understand the many links between heart disease and cancer, the two leading causes of death worldwide, the American Heart Association (AHA), the world's leading voluntary organization dedicated to a world of longer, healthier lives, announced grants focused on this area of scientific research. More than $11 million in research grants has been awarded to create the AHA's newest Strategically Focused Research Network on disparities in cardio-oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
Reversal speeds creation of important molecule
(Rice University) A Rice University lab's reverse approach to making halichondrin B is the shortest route to what it referred to as a rather complex and important molecule and the parent compound of eribulin, the latter being used to treat breast cancer and liposarcoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
Using light to treat drug-resistant tumors
(University of Texas at Arlington) A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
A promising two-punch therapy for Langerhans cell histiocytosis
(Baylor College of Medicine) A novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
Study sheds light on persistent racial disparities in prostate cancer care in the United States
(NYU Langone Health / NYU Grossman School of Medicine) Black men most likely to benefit from advanced prostate cancer therapies are 11% less likely to get them than non-Black men. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news
